Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
HEDA Ventures is a venture capital firm located in Sunnyvale, California, focusing on early-stage investments. The firm primarily targets companies in the biotech, healthcare, and technology, media, and telecommunications (TMT) sectors. They aim to support entrepreneurs in expanding their businesses and accessing global market opportunities.
HEDA Ventures invests in early-stage companies, particularly in the biotech, healthcare, and TMT sectors. They provide funding at the seed and Series A stages, targeting businesses that are developing breakthroughs in these industries.
Notable portfolio companies include NeuCyte, which focuses on solutions for Central Nervous System disorders; Paragon Genomics, known for its ultra-high multiplex PCR-based target enrichment solutions; Taproot, which develops next-generation biomaterials for medical applications; and Arthrosi Therapeutics, addressing treatment needs for gout and chronic kidney diseases.
Email your pitch deck to info@hedaventures.com for consideration.
Yes, HEDA Ventures often leads funding rounds for the companies they invest in, particularly at the seed and Series A stages.
HEDA Ventures is open to follow-on investments, especially for companies that demonstrate significant growth and potential in their respective sectors.
Specific details about the size of HEDA Ventures' current fund are not publicly available.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.